Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Micro-CHI is a microchip-based implant technology designed for controlled, programmable drug delivery. The implant contains multiple discrete doses of drugs sealed in reservoirs that can be electrically opened on demand via wireless communication. This allows precise timing and dosing of medication, improving compliance especially in chronic diseases such as diabetes and osteoporosis. The device includes control electronics like a real-time clock, microcontroller, and radio frequency communication to enable remote activation of drug release. It offers flexibility to deliver multiple drugs customized per patient needs with scheduled automated dosing, potentially reducing side effects by targeting specific sites and adjusting doses according to physiological changes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Micro-CHI.